There is 1 paper on increased aminotransferases in aging research: 1 trial in people.
1 paper studies it
See all 1 papers on increased aminotransferases
- Human trial1
Latest
The Lancet Oncology
Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity
Non-randomized trial in 55 peopleNavitoclax